Hematologic Malignancy Prevalence in Hidradenitis Suppurativa: A Cross-Sectional Study
Dermatology and Skin Science · 2026
DOI: 10.53941/dss.2026.100010 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Dermatology and Skin Science, 2026. Verfasst von Parsa Abdi und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with substantial comorbidity. Evidence regarding the co-occurrence of HS and recorded hematologic malignancy diagnoses in large, diverse electronic health record populations remains limited.
Methods
We conducted a cross-sectional analysis using standardized electronic health record data from the All of Us Research Program. Adults aged 18–90 years with available electronic health records were included. Participants with HS were identified using ICD-10-CM and SNOMED diagnostic codes matched to controls without recorded HS in a 1:4 ratio using nearest-neighbor propensity-score. Matching was based on age, gender, and race/ethnicity. Matching was performed without replacement using a caliper of 0.2 standard deviations of the logit of the propensity score. Multivariable logistic regression models with cluster-robust standard errors for matched sets were used to evaluate associations between HS and recorded hematologic malignancy diagnoses.
Results
The matched cohort included 2636 participants with HS and 10,544 controls. The primary complete-case analysis included 1544 participants with HS and 6176 controls. Any recorded hematologic malignancy was identified in 72 participants with HS (4.66%) and 151 controls (2.44%) and was associated with HS after covariate adjustment (adjusted odds ratio [aOR], 2.04; 95% CI, 1.62–2.47). Recorded diagnoses of multiple myeloma (22 [1.42%] vs. 25 [0.40%]; aOR, 3.64; 95% CI, 2.29–6.24), leukemia (24 [1.55%] vs. 41 [0.66%]; aOR, 2.30; 95% CI, 1.46–3.82), and malignant lymphoma (39 [2.53%] vs. 95 [1.54%]; aOR, 1.83; 95% CI, 1.30–2.57) were also more frequently recorded among participants with HS.
Conclusions
HS was associated with increased adjusted odds of recorded hematologic malignancies in this large, diverse cohort. Longitudinal studies are needed to establish temporality and causality.
Zitieren
APA
Abdi, P., Haq, Z., Diaz, M. J., Raja, M., McMullen, E., Asgarpour, J., Emam, S., Gniadecki, R., & Croitoru, D. (2026). Hematologic Malignancy Prevalence in Hidradenitis Suppurativa: A Cross-Sectional Study. Dermatology and Skin Science. https://doi.org/10.53941/dss.2026.100010
Vancouver
Abdi P, Haq Z, Diaz MJ, Raja M, McMullen E, Asgarpour J, et al. Hematologic Malignancy Prevalence in Hidradenitis Suppurativa: A Cross-Sectional Study. Dermatology and Skin Science. 2026. doi:10.53941/dss.2026.100010
BibTeX
@article{Abdi2026,
author = {Abdi, Parsa and Haq, Zaim and Diaz, Michael J. and Raja, Maheen and McMullen, Eric and Asgarpour, Jessica and Emam, Sepideh and Gniadecki, Robert and Croitoru, David},
title = {Hematologic Malignancy Prevalence in Hidradenitis Suppurativa: A Cross-Sectional Study},
journal = {Dermatology and Skin Science},
year = {2026},
doi = {10.53941/dss.2026.100010}
}
EUVIMED